Blockade of porcine carotid vascular responses to sumatriptan by GR127935, a selective 5-HT1D receptor antagonist

British Journal of Pharmacology

Volumn 118, Issue 1, 1996, Pages 85-92

  De Vries, Peter ^a   Heiligers, Jan P C ^a   Villalón, Carlos M ^b   Saxena, Pramod R ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Antimigraine drugs; Arteriovenous anastomoses; Carotid artery; GR127935; Migraine; Pig carotid vascular responses; Sumatriptan

Indexed keywords

N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ADIPOSE TISSUE; ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CAPILLARY FLOW; CAROTID ARTERY; CAROTID ARTERY FLOW; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EAR; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SWINE; VASODILATATION;

ANIMALS; ARTERIOVENOUS ANASTOMOSIS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERY, COMMON; HEART RATE; OXADIAZOLES; PIPERAZINES; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SUMATRIPTAN; SWINE;

EID: 0029873939     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15370.x     Document Type: Article

References (45)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A., 90, 408-412.
2. 1D-like receptors, and a comparison with 'grafted' veins. Naunyn-Schmied. Arch. Pharmacol., 345, 500-508.
3. BEATTIE, D.T., CONNOR, H.E., FENIUK, W. & HUMPHREY, P.P.A. (1994). The pharmacology of sumatriptan. Rev. Contemp. Pharmacother., 5, 285-294.
4. CAEKEBEKE, J.F.V., FERRARI, M.D., ZWETSLOOT, C.P., JANSEN, J. & SAXENA, P.R. (1992). Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology, 42, 1522-1526.
5. 1D antagonists. J. Med. Chem., 37, 2253-2257.
6. 1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries. Br. J. Pharmacol., 112, 939-945.
7. 1D receptors. Naunyn-Schmied. Arch. Pharmacol., 352 (Suppl), R15.
8. 1-like receptors. Br. J. Pharmacol., 104, 183-189.
9. 1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br. J. Pharmacol., 102, 323-330.
10. DEN BOER, M.O., VAN WOERKENS, L.J., SOMERS, J.A.E., DUNCKER, D.J., LACHMANN, B., SAXENA, P.R. & VERDOUW, P.D. (1993). On the preservation and regulation of vascular tone in arteriovenous anastomoses during anesthesia. J. Appl. Physiol., 75, 782-789.
11. 1D-receptors involved? Naunyn-Schmied. Arch. Pharmacol., 345, 509-515.
12. 1A receptor agonist flesinoxan in the cat. J. Cardiovasc. Pharmacol., 14, 770-776.
13. FENIUK, W., HUMPHREY, P.P.A. & PERREN, M.J. (1989). The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br. J. Pharmacol., 96, 83-90.
14. FERRARI, M.D. & SAXENA, P.R. (1993). Clinical and experimental effects of sumtriptan in humans. Trends Pharmacol. Sci., 14, 129-133.
15. 1D type serotonin receptor. Mol. Pharmacol., 40, 143-148.
16. 1D binding sites. Br. J. Pharmacol., 102, 227-233.
17. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol., 44, 242-246.
18. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
19. HUMPHREY, P.P.A., APPERLEY, E., FENIUK, W. & PERREN, M.J. (1990). A rational approach to identifying a fundamentally new drug for the treatment of migraine. In Cardiovascular Pharmacology of 5-Hydroxytryptamine: Prospective Therapeutic Applications. ed. Saxena, P.R., Wallis, D.I., Wouters, W. & Bevan, P. pp.416-431. Dordrecht: Kluwer Academic Publishers.
20. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123-1132.
21. JANSEN, I., OLESEN, J. & EDVINSSON, L. (1993). 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol. Scand., 147, 141-150.
22. 1D receptor in the action of sumatriptan. Eur. J. Pharmacol., 227, 99-102.
23. 1Dα receptor sites. Neuropharmacology, 34, 235-237.
24. 1D binding sites. Eur. J. Pharmacol., 163, 133-136.
25. 1D subtype. Br. J. Pharmacol., 102, 191-197.
26. 1Dα serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc. Natl. Acad. Sci. U.S.A., 91, 3666-3669.
27. SAXENA, P.R. (1990). Is there still a case for the shunt hypothesis in migraine? In Migraine: a Spectrum of Ideas. ed. Sandler, M. & Collins, G.M. pp.191-199. Oxford: Oxford University Press.
28. SAXENA, P.R., SCHAMHARDT, H.C., FORSYTH, R.P. & LOEVE, J. (1980). Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Camp. Progr. Biomed., 12, 63-84.
29. SAXENA, P.R. & TFELT-HANSEN, P. (1993). Sumatriptan. In The Headaches. ed. Olesen, J., Tfelt-Hansen, P. & Welch, K.M.A. pp.329-341. New York: Raven Press Ltd.
30. SAXENA, P.R. & VERDOUW, P.D. (1982). Redistribution by 5-HT on carotid arterial blood at the expense of arteriovenous blood flow. J. Physiol., 332, 501-520.
31. SAXENA, P.R. & VILLALÓN, C.M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol., 15 (Suppl. 7), S17-S34.
32. SAXENA, P.R. & VILLALÓN, C.M. (1991). 5-Hydroxytryptamine, a chameleon in the heart. Trends Pharmacol. Sci., 12, 223-227.
33. 1D receptors. Naunyn-Schmied. Arch. Pharmacol., 340, 135-138.
34. 1D receptor subtype. J. Pharmacol. Exp. Ther., 252, 387-395.
35. 1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn-Schmied. Arch. Pharmacol., 337, 602-608.
36. 1D receptor antagonist. Br. J. Pharmacol., 110, 9P.
37. 1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus. Neuropharmacology, 33, 393-402.
38. THE SUBCUTANEOUS SUMATRIPTAN INTERNATIONAL STUDY GROUP. (1991). Treatment of migraine with sumatriptan. New Engl. J. Med., 325, 316-321.
39. VILLALÓN, C.M., BOM, A.H., DEN BOER, M.O., HEILIGERS, J.P.C. & SAXENA, P.R. (1992). Effects of S9977, a potential antimigraine drug, and dihydroergotamine on carotid blood flow fractionation in the pig. Pharmacol. Res., 25, 125-137.
40. 1D receptor subtype. Eur. J. Pharmacol., 190, 167-176.
41. VILLALÓN, C.M., RAMÍREZ-SAN JUAN, E., CASTILLO, C., CASTILLO, E., LÓPEZ-MUÑOZ, F.J. & TERRÓN, J.A. (1995). Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vasosympathectomized dogs. Br. J. Pharmacol., 116, 2778-2784.
42. 1D subtype. Br. J. Pharmacol., 113, 13-20.
43. 1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmied. Arch. Pharmacol., 337, 595-601.
44. 1Dβ receptors. Br. J. Pharmacol., 114, 362P.
45. 1Dα. Proc. Natl. Acad. Sci. U.S.A., 89, 3630-3634.